![]() |
市場調查報告書
商品編碼
1667638
前列腺肥大症(BPH)治療設備的全球市場:規模,佔有率,趨勢分析(2025年~2031年):MedCoreBPH Treatment Device Market Size, Share & Trend Analysis | Global | 2025-2031 | MedCore | Includes: TURP Market, Laser BPH Fibre Treatment Market, and 2 more |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
全球良性前列腺增生 (BPH) 治療設備市場規模預計將在 2024 年超過 10 億美元,以 5.1% 的複合年增長率增長,到 2031 年將超過 14 億美元。
藥物治療是主要的市場阻礙因素,到 2024 年將有超過 90% 的 BPH 患者選擇藥物治療而非介入治療。與傳統手術相比,UroLift® 和 Rezum® 等微創 BPH 治療因恢復時間更短、風險更低而越來越受到支持。钬雷射和铥雷射由於其在組織去除和凝固方面的精確度和有效性而越來越被採用。
本報告提供全球前列腺肥大症(BPH)治療設備市場相關調查,提供市場概要,以及各市場區隔,各地區趨勢,競爭情形等資訊。
The global benign prostatic hyperplasia (BPH) treatment device market was valued at over $1.0 billion in 2024 and is projected to grow at a CAGR of 5.1%, reaching over $1.4 billion by 2031.
Market Segments Covered:
* Monopolar Electrodes
* Bipolar Electrodes
* Holmium & Thulium Laser Equipment
* Holmium & Thulium Laser Fibers
Comprehensive Market Insights
Global BPH Treatment Device Market Trends
Market Share Insights
Top Competitors in the Global BPH Treatment Device Market (2024):
1 Teleflex
* Market leader, with a monopoly in the UroLift(R) segment.
2 Boston Scientific
* Dominant leader in the laser BPH market.
* Monopolistic position in the Rezum(R) market.
* Key Products: VersaPulse(TM) PowerSuite(TM) Holmium Laser, Lumenis Pulse(TM) Holmium Lasers (100W & 120W).
* Mergers & Acquisitions: Acquired Lumenis' global surgical business in 2021.
3 Olympus
Market Segmentation Summary
Key Market Segments:
Global Research Scope
Report Details:
* North America: U.S., Canada
* Latin America: Brazil, Mexico, Argentina, etc.
* Western Europe: U.K., Germany, France, Spain, Italy, etc.
* Central & Eastern Europe: Russia, Poland, Turkey, etc.
* Middle East: Saudi Arabia, UAE, Israel, etc.
* Asia Pacific: China, Japan, India, Australia, etc.
* Africa: South Africa, Nigeria, Egypt, etc.
Quantitative Coverage:
Qualitative Coverage:
Data Sources:
Table of Contents
BPH Treatment Device Market
List of Charts
List of Figures